Atlas Trials

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

Clinical trial NCT03679546 · COMPLETED

Trial details

NCT number
NCT03679546
Sponsor
Rennes University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2019-01-04
Primary completion
2024-12-16
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.